Drerup Michelle, Roth Alicia, Kane Alexa, Sullivan Amy B
Sleep Disorders Center, Cleveland Clinic, Cleveland, OH, USA.
Mellen Center for MS, Cleveland Clinic, Cleveland, OH, USA.
Nat Sci Sleep. 2021 Feb 16;13:201-207. doi: 10.2147/NSS.S256676. eCollection 2021.
The prevalence of sleep disorders in individuals with multiple sclerosis (MS) is 3-5 times higher compared to the general population. Insomnia Disorder, defined as difficulty falling asleep, maintaining sleep or waking up too early, can lead to significant fatigue, the most common and disabling symptom of MS. In addition, fatigue and insomnia in patients with MS also can overlap with and exacerbate other psychological and physical symptoms. Cognitive behavioral therapy for insomnia (CBT-I) has been shown as an effective treatment for chronic insomnia and burgeoning research has demonstrated the effectiveness of this treatment for insomnia in individuals with a variety of comorbid medical conditions including MS. The purpose of the current review will explore the literature surrounding the prevalence and impact of sleep disorders and fatigue in MS. Additionally, this review will address practical ways to help individuals with MS manage fatigue as well as how to modify typical standard behavioral treatments for insomnia to take into account special considerations for individuals with MS based on the level of disability and other comorbid issues that impact sleep.
与普通人群相比,多发性硬化症(MS)患者睡眠障碍的患病率要高出3至5倍。失眠障碍被定义为入睡困难、维持睡眠困难或过早醒来,可导致严重疲劳,这是MS最常见且致残的症状。此外,MS患者的疲劳和失眠还可能与其他心理和身体症状重叠并使其加重。失眠的认知行为疗法(CBT-I)已被证明是治疗慢性失眠的有效方法,并且新兴研究已证明该疗法对包括MS在内的各种合并内科疾病患者的失眠有效。本综述的目的是探讨围绕MS患者睡眠障碍和疲劳的患病率及影响的文献。此外,本综述还将探讨帮助MS患者管理疲劳的实用方法,以及如何根据残疾程度和影响睡眠的其他合并问题,对失眠的典型标准行为疗法进行调整,以考虑到MS患者的特殊情况。